Data |
Ora |
Fonte |
Titolo |
19/4/2024 | 22:05 | EDGAR2 | Form ARS - Annual Report to Security Holders |
19/4/2024 | 22:04 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
19/4/2024 | 22:02 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
19/3/2024 | 22:10 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
19/3/2024 | 22:02 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
19/3/2024 | 12:09 | EDGAR2 | Form 8-K - Current report |
21/11/2023 | 00:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
21/11/2023 | 00:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
06/11/2023 | 22:30 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
30/10/2023 | 21:15 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
27/10/2023 | 23:17 | EDGAR2 | Form 8-K - Current report |
27/10/2023 | 22:02 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
26/10/2023 | 23:34 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
26/10/2023 | 23:00 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
26/10/2023 | 22:46 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
21/10/2023 | 03:23 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
17/10/2023 | 23:47 | GLOBE | Talaris Therapeutics Announces Stockholder Approval of.. |
10/10/2023 | 22:32 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
10/10/2023 | 22:30 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
07/10/2023 | 02:01 | DJN | Stocks to Watch: Shift Technologies, Talaris Therapeutics,.. |
06/10/2023 | 23:30 | EDGAR2 | Form 8-K - Current report |
06/10/2023 | 23:27 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
06/10/2023 | 23:26 | EDGAR2 | Form 8-K - Current report |
06/10/2023 | 23:09 | GLOBE | Talaris Therapeutics Declares Special Dividend In Connection.. |
04/10/2023 | 14:30 | GLOBE | New York Blood Center Enterprises Acquires Commercial-Scale.. |
26/9/2023 | 14:24 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
26/9/2023 | 14:21 | EDGAR2 | Form 8-K - Current report |
15/9/2023 | 12:31 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
13/9/2023 | 22:28 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
13/9/2023 | 15:14 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
13/9/2023 | 15:13 | EDGAR2 | Form 8-K - Current report |
11/9/2023 | 22:47 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
28/8/2023 | 13:38 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
25/8/2023 | 22:34 | EDGAR2 | Form S-4/A - Registration of securities, business.. |
14/8/2023 | 13:53 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
22/6/2023 | 13:30 | GLOBE | Talaris Therapeutics and Tourmaline Bio Announce Merger.. |
26/5/2023 | 13:00 | GLOBE | Talaris Therapeutics Announces Leadership Transition |